BACH1 promotes lung cancer cell migration and invasion by inducing the expression of metabolic genes (such as HK2) leading to an increase in glycolysis [40], and thus BACH1 inhibitors have the potential to reduce the spread of lung cancer cells. Here, HK2 is linked to lung carcinoma.